G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
PP&E Net Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
PP&E Net
â‚ą8.2B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
PP&E Net
â‚ą59.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
PP&E Net
â‚ą113B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
7%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
PP&E Net
â‚ą69.1B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
PP&E Net
â‚ą35.8B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
PP&E Net
â‚ą31.4B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's PP&E Net?
PP&E Net
8.2B INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's PP&E Net amounts to 8.2B INR.

What is Glenmark Life Sciences Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
9%

Over the last year, the PP&E Net growth was 0%. The average annual PP&E Net growth rates for Glenmark Life Sciences Ltd have been 12% over the past three years , 9% over the past five years .

Back to Top